Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-08-18

AUTHORS

Xiaoli Zhu, Qianming Bai, Yongming Lu, Peng Qi, Jianhui Ding, Jialei Wang, Xiaoyan Zhou

ABSTRACT

BackgroundThe rare epidermal growth factor receptor (EGFR) mutation S768I has only been reported sporadically in patients with lung adenocarcinoma (AC).ObjectiveThis study aimed to investigate the prevalence of the S768I mutation in Chinese patients with lung AC and to retrospectively analyze the response of S768I mutants to tyrosine kinase inhibitors (TKIs).Patients and MethodsA total of 6698 tissue specimens of lung AC were collected from the Department of Pathology of Shanghai Cancer Center of Fudan University between 2013 and 2015 and screened for EGFR mutations. Previously reported cases were combined with our data to evaluate the response of the S768I mutants to TKIs.ResultsThirty-five patients (0.52 %, 35/6698) harbored the S768I mutation, including 8 (22.9 %) with just the S768I mutation and 27 (77.1 %) with compound mutations of S768I and other EGFR mutations (including G719X and L858R). The median progression-free survival (PFS) of the 8 cases with available PFS data was 5.0 months (95 % confidential interval: 0.4–9.6 months). We combined our cases with the sporadic cases from 14 previous reports (total 49 cases) to assess the response to TKIs and found that the objective response rate was 40.0 %, 74.9 %, and 60.0 % for S768I-only mutants, S768I+G719X mutants, and S768I+L858R mutants, respectively.ConclusionsS786I mutation is rare in lung AC and is frequently accompanied by G719X, L858R, or other EGFR mutations. Patients harboring only the S768I mutation appear to be more sensitive to TKIs than those with the wild-type EGFR. The S768I mutation may increase the sensitivity of G719X to TKIs but not the sensitivity of L858R to TKIs. More... »

PAGES

81-88

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11523-016-0455-4

DOI

http://dx.doi.org/10.1007/s11523-016-0455-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022468356

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27538584


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma of Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ErbB Receptors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Xiaoli", 
        "id": "sg:person.01311726114.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311726114.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bai", 
        "givenName": "Qianming", 
        "id": "sg:person.01257353151.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257353151.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Yongming", 
        "id": "sg:person.01256346341.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256346341.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qi", 
        "givenName": "Peng", 
        "id": "sg:person.01243202604.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243202604.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.452404.3", 
          "name": [
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
            "Department of Radiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ding", 
        "givenName": "Jianhui", 
        "id": "sg:person.01357617006.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357617006.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.452404.3", 
          "name": [
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
            "Department of Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Jialei", 
        "id": "sg:person.01372632442.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372632442.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China", 
            "Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Xiaoyan", 
        "id": "sg:person.01010610662.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010610662.09"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/srep13959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049650210", 
          "https://doi.org/10.1038/srep13959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-13-141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036333599", 
          "https://doi.org/10.1186/1476-4598-13-141"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08-18", 
    "datePublishedReg": "2016-08-18", 
    "description": "BackgroundThe rare epidermal growth factor receptor (EGFR) mutation S768I has only been reported sporadically in patients with lung adenocarcinoma (AC).ObjectiveThis study aimed to investigate the prevalence of the S768I mutation in Chinese patients with lung AC and to retrospectively analyze the response of S768I mutants to tyrosine kinase inhibitors (TKIs).Patients and MethodsA total of 6698 tissue specimens of lung AC were collected from the Department of Pathology of Shanghai Cancer Center of Fudan University between 2013 and 2015 and screened for EGFR mutations. Previously reported cases were combined with our data to evaluate the response of the S768I mutants to TKIs.ResultsThirty-five patients (0.52\u00a0%, 35/6698) harbored the S768I mutation, including 8 (22.9\u00a0%) with just the S768I mutation and 27 (77.1\u00a0%) with compound mutations of S768I and other EGFR mutations (including G719X and L858R). The median progression-free survival (PFS) of the 8 cases with available PFS data was 5.0\u00a0months (95\u00a0% confidential interval: 0.4\u20139.6\u00a0months). We combined our cases with the sporadic cases from 14 previous reports (total 49 cases) to assess the response to TKIs and found that the objective response rate was 40.0\u00a0%, 74.9\u00a0%, and 60.0\u00a0% for S768I-only mutants, S768I+G719X mutants, and S768I+L858R mutants, respectively.ConclusionsS786I mutation is rare in lung AC and is frequently accompanied by G719X, L858R, or other EGFR mutations. Patients harboring only the S768I mutation appear to be more sensitive to TKIs than those with the wild-type EGFR. The S768I mutation may increase the sensitivity of G719X to TKIs but not the sensitivity of L858R to TKIs.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11523-016-0455-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7010533", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1036678", 
        "issn": [
          "1776-2596", 
          "1776-260X"
        ], 
        "name": "Targeted Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "progression-free survival", 
      "lung adenocarcinoma", 
      "EGFR mutations", 
      "S768I mutation", 
      "median progression-free survival", 
      "Shanghai Cancer Center", 
      "objective response rate", 
      "Department of Pathology", 
      "kinase inhibitors", 
      "wild-type EGFR", 
      "tyrosine kinase inhibitors", 
      "Cancer Center", 
      "Chinese patients", 
      "retrospective analysis", 
      "response rate", 
      "patients", 
      "adenocarcinoma", 
      "TKIs", 
      "tissue specimens", 
      "sporadic cases", 
      "S768I", 
      "PFS data", 
      "Fudan University", 
      "compound mutations", 
      "G719X", 
      "previous reports", 
      "L858R", 
      "literature review", 
      "inhibitors", 
      "response", 
      "mutations", 
      "cases", 
      "prevalence", 
      "EGFR", 
      "pathology", 
      "months", 
      "survival", 
      "total", 
      "sensitivity", 
      "report", 
      "Department", 
      "review", 
      "data", 
      "study", 
      "specimens", 
      "center", 
      "rate", 
      "mutants", 
      "analysis", 
      "University", 
      "rare epidermal growth factor receptor (EGFR) mutation S768I", 
      "epidermal growth factor receptor (EGFR) mutation S768I", 
      "growth factor receptor (EGFR) mutation S768I", 
      "factor receptor (EGFR) mutation S768I", 
      "receptor (EGFR) mutation S768I", 
      "mutation S768I", 
      "S768I mutants", 
      "available PFS data", 
      "ConclusionsS786I mutation", 
      "sensitivity of G719X", 
      "sensitivity of L858R"
    ], 
    "name": "Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review", 
    "pagination": "81-88", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022468356"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11523-016-0455-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27538584"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11523-016-0455-4", 
      "https://app.dimensions.ai/details/publication/pub.1022468356"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_686.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11523-016-0455-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11523-016-0455-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11523-016-0455-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11523-016-0455-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11523-016-0455-4'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      22 PREDICATES      101 URIs      91 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11523-016-0455-4 schema:about N072a94ff40b34f65b64897d7c3389ac8
2 N090a77d7b35f42688c9d367b6c32bd68
3 N0a17073ea16641c5bba3a0162fc19cbd
4 N111351c2c2fa4ae2979aadd191ac843e
5 N190f30220c5a4296a73130cc2811b922
6 N55d5fb0d3b6944e09e93d7cc0606bf3e
7 N8a81abad22d24c93b6ed747765c9b19b
8 N948fb3f3ebd444e88b3cf773fd851324
9 Na8012156ddba472bb84a00eeb5ad2062
10 Naff287b7759c4b339db45078cc9a6fb2
11 Ne17a090f3cef46a8910eb1cd0110db33
12 Nf91ce63bc7c14d5da2ac38ee7b4f0a88
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N2ebcd8f18a7649faaa8385489d308863
16 schema:citation sg:pub.10.1038/srep13959
17 sg:pub.10.1186/1476-4598-13-141
18 schema:datePublished 2016-08-18
19 schema:datePublishedReg 2016-08-18
20 schema:description BackgroundThe rare epidermal growth factor receptor (EGFR) mutation S768I has only been reported sporadically in patients with lung adenocarcinoma (AC).ObjectiveThis study aimed to investigate the prevalence of the S768I mutation in Chinese patients with lung AC and to retrospectively analyze the response of S768I mutants to tyrosine kinase inhibitors (TKIs).Patients and MethodsA total of 6698 tissue specimens of lung AC were collected from the Department of Pathology of Shanghai Cancer Center of Fudan University between 2013 and 2015 and screened for EGFR mutations. Previously reported cases were combined with our data to evaluate the response of the S768I mutants to TKIs.ResultsThirty-five patients (0.52 %, 35/6698) harbored the S768I mutation, including 8 (22.9 %) with just the S768I mutation and 27 (77.1 %) with compound mutations of S768I and other EGFR mutations (including G719X and L858R). The median progression-free survival (PFS) of the 8 cases with available PFS data was 5.0 months (95 % confidential interval: 0.4–9.6 months). We combined our cases with the sporadic cases from 14 previous reports (total 49 cases) to assess the response to TKIs and found that the objective response rate was 40.0 %, 74.9 %, and 60.0 % for S768I-only mutants, S768I+G719X mutants, and S768I+L858R mutants, respectively.ConclusionsS786I mutation is rare in lung AC and is frequently accompanied by G719X, L858R, or other EGFR mutations. Patients harboring only the S768I mutation appear to be more sensitive to TKIs than those with the wild-type EGFR. The S768I mutation may increase the sensitivity of G719X to TKIs but not the sensitivity of L858R to TKIs.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf Nbd9ff85bccdc4dd1bad9e51e9740c167
25 Nd7d72ca373a541d9861fc9095d7b23cd
26 sg:journal.1036678
27 schema:keywords Cancer Center
28 Chinese patients
29 ConclusionsS786I mutation
30 Department
31 Department of Pathology
32 EGFR
33 EGFR mutations
34 Fudan University
35 G719X
36 L858R
37 PFS data
38 S768I
39 S768I mutants
40 S768I mutation
41 Shanghai Cancer Center
42 TKIs
43 University
44 adenocarcinoma
45 analysis
46 available PFS data
47 cases
48 center
49 compound mutations
50 data
51 epidermal growth factor receptor (EGFR) mutation S768I
52 factor receptor (EGFR) mutation S768I
53 growth factor receptor (EGFR) mutation S768I
54 inhibitors
55 kinase inhibitors
56 literature review
57 lung adenocarcinoma
58 median progression-free survival
59 months
60 mutants
61 mutation S768I
62 mutations
63 objective response rate
64 pathology
65 patients
66 prevalence
67 previous reports
68 progression-free survival
69 rare epidermal growth factor receptor (EGFR) mutation S768I
70 rate
71 receptor (EGFR) mutation S768I
72 report
73 response
74 response rate
75 retrospective analysis
76 review
77 sensitivity
78 sensitivity of G719X
79 sensitivity of L858R
80 specimens
81 sporadic cases
82 study
83 survival
84 tissue specimens
85 total
86 tyrosine kinase inhibitors
87 wild-type EGFR
88 schema:name Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review
89 schema:pagination 81-88
90 schema:productId N52d3012c8b8a4f90820aa9f602d34b1d
91 Na663d542ee55491fb54f2bb6f4317793
92 Nfd444c50c5354ab8ab709fd2abaca668
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022468356
94 https://doi.org/10.1007/s11523-016-0455-4
95 schema:sdDatePublished 2022-01-01T18:38
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher N75f22d092d394c71943d3ac7ad596d67
98 schema:url https://doi.org/10.1007/s11523-016-0455-4
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N072a94ff40b34f65b64897d7c3389ac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Disease-Free Survival
104 rdf:type schema:DefinedTerm
105 N090a77d7b35f42688c9d367b6c32bd68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Aged
107 rdf:type schema:DefinedTerm
108 N0a17073ea16641c5bba3a0162fc19cbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Protein Kinase Inhibitors
110 rdf:type schema:DefinedTerm
111 N111351c2c2fa4ae2979aadd191ac843e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Adenocarcinoma
113 rdf:type schema:DefinedTerm
114 N190f30220c5a4296a73130cc2811b922 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adenocarcinoma of Lung
116 rdf:type schema:DefinedTerm
117 N20ceb6a77e5d4e55ae0636a964f96863 rdf:first sg:person.01372632442.73
118 rdf:rest N49081d857df64e7b942d726e7a01432b
119 N2ebcd8f18a7649faaa8385489d308863 rdf:first sg:person.01311726114.78
120 rdf:rest N945dee04e38c4b56ab51c6541d2068b0
121 N3b1a504cd68644dda01180ef74321589 rdf:first sg:person.01243202604.73
122 rdf:rest Nf8ce22d5a49d4f3197e7cb8acc0387db
123 N49081d857df64e7b942d726e7a01432b rdf:first sg:person.01010610662.09
124 rdf:rest rdf:nil
125 N52d3012c8b8a4f90820aa9f602d34b1d schema:name dimensions_id
126 schema:value pub.1022468356
127 rdf:type schema:PropertyValue
128 N55d5fb0d3b6944e09e93d7cc0606bf3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Retrospective Studies
130 rdf:type schema:DefinedTerm
131 N75f22d092d394c71943d3ac7ad596d67 schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N8a81abad22d24c93b6ed747765c9b19b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name ErbB Receptors
135 rdf:type schema:DefinedTerm
136 N8ff549add5744ac5aa7d622f50bea83a rdf:first sg:person.01256346341.70
137 rdf:rest N3b1a504cd68644dda01180ef74321589
138 N945dee04e38c4b56ab51c6541d2068b0 rdf:first sg:person.01257353151.80
139 rdf:rest N8ff549add5744ac5aa7d622f50bea83a
140 N948fb3f3ebd444e88b3cf773fd851324 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Mutation
142 rdf:type schema:DefinedTerm
143 Na663d542ee55491fb54f2bb6f4317793 schema:name doi
144 schema:value 10.1007/s11523-016-0455-4
145 rdf:type schema:PropertyValue
146 Na8012156ddba472bb84a00eeb5ad2062 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Lung Neoplasms
148 rdf:type schema:DefinedTerm
149 Naff287b7759c4b339db45078cc9a6fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Middle Aged
151 rdf:type schema:DefinedTerm
152 Nbd9ff85bccdc4dd1bad9e51e9740c167 schema:volumeNumber 12
153 rdf:type schema:PublicationVolume
154 Nd7d72ca373a541d9861fc9095d7b23cd schema:issueNumber 1
155 rdf:type schema:PublicationIssue
156 Ne17a090f3cef46a8910eb1cd0110db33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 Nf8ce22d5a49d4f3197e7cb8acc0387db rdf:first sg:person.01357617006.14
160 rdf:rest N20ceb6a77e5d4e55ae0636a964f96863
161 Nf91ce63bc7c14d5da2ac38ee7b4f0a88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nfd444c50c5354ab8ab709fd2abaca668 schema:name pubmed_id
165 schema:value 27538584
166 rdf:type schema:PropertyValue
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
171 schema:name Oncology and Carcinogenesis
172 rdf:type schema:DefinedTerm
173 sg:grant.7010533 http://pending.schema.org/fundedItem sg:pub.10.1007/s11523-016-0455-4
174 rdf:type schema:MonetaryGrant
175 sg:journal.1036678 schema:issn 1776-2596
176 1776-260X
177 schema:name Targeted Oncology
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.01010610662.09 schema:affiliation grid-institutes:grid.11841.3d
181 schema:familyName Zhou
182 schema:givenName Xiaoyan
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010610662.09
184 rdf:type schema:Person
185 sg:person.01243202604.73 schema:affiliation grid-institutes:grid.11841.3d
186 schema:familyName Qi
187 schema:givenName Peng
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243202604.73
189 rdf:type schema:Person
190 sg:person.01256346341.70 schema:affiliation grid-institutes:grid.11841.3d
191 schema:familyName Lu
192 schema:givenName Yongming
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256346341.70
194 rdf:type schema:Person
195 sg:person.01257353151.80 schema:affiliation grid-institutes:grid.11841.3d
196 schema:familyName Bai
197 schema:givenName Qianming
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257353151.80
199 rdf:type schema:Person
200 sg:person.01311726114.78 schema:affiliation grid-institutes:grid.11841.3d
201 schema:familyName Zhu
202 schema:givenName Xiaoli
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311726114.78
204 rdf:type schema:Person
205 sg:person.01357617006.14 schema:affiliation grid-institutes:grid.452404.3
206 schema:familyName Ding
207 schema:givenName Jianhui
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357617006.14
209 rdf:type schema:Person
210 sg:person.01372632442.73 schema:affiliation grid-institutes:grid.452404.3
211 schema:familyName Wang
212 schema:givenName Jialei
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372632442.73
214 rdf:type schema:Person
215 sg:pub.10.1038/srep13959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049650210
216 https://doi.org/10.1038/srep13959
217 rdf:type schema:CreativeWork
218 sg:pub.10.1186/1476-4598-13-141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036333599
219 https://doi.org/10.1186/1476-4598-13-141
220 rdf:type schema:CreativeWork
221 grid-institutes:grid.11841.3d schema:alternateName Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China
222 schema:name Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China
223 Department of Pathology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China
224 rdf:type schema:Organization
225 grid-institutes:grid.452404.3 schema:alternateName Department of Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China
226 Department of Radiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China
227 schema:name Department of Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China
228 Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China
229 Department of Radiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...